Skip to NavigationSkip to content

Pharmafile - Medical Communications

FDA investigating if carcinogen NDMA is in diabetes drug
The FDA is looking into if the diabetes drug metformin has unsafe levels of a cancer-causing chemical.
Sage Therapeutics' depression drug falls short at Phase 3
Sage Therapeutics has announced that its candidate SAGE-217 flopped in Phase 3 trials investigating its efficacy in symptom reduction for major...
Anti-vaxx movement complicit in 140,000 global measles deaths in 2018, mostly in children
Over 140,000 people died from measles last year, with most of them being children under five, according to World Health Organization (WHO) and the US...
Top Ten most popular articles on Pharmafile.com this week
Widespread bribery in India’s pharma industry, Purdue Pharma President ignored addiction concerns with OxyContin, and Lynparza scores NICE...
>> More Medical Communications News Stories

Features

Transactions in the pharma sector: Through the EU merger review looking-glass

With mergers and acquisitions back in full swing after a period of drought, Alec Burnside (Partner) and Delphine Strohl (Associate) of global law...

>> More Features

Appointments

Dr Richard Torbett is named as the new Chief Executive of the ABPI

The Association of the British Pharmaceutical Industry (ABPI) has appointed Dr Richard Torbett as its new Chief Executive. He will assume the...

For more appointments click here

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches